InMed Pharmaceuticals Inc (INM): Hi Investor Jesus, InMed is still relati...

Replies (1) Next 10 Prev Next

Send PM Follow Ignore

Followers	52
Posts	601
Boards Moderated	0
Alias Born	05/25/2014

PharmaGreen007

Re: Investor Jesus post# 783

Friday, 03/20/2015 7:59:41 PM

Friday, March 20, 2015 7:59:41 PM

Hi Investor Jesus, InMed is still relatively unknown in the States right now. On the Canadian market it averages between 300k a day.

The company is very compelling and has one of the most qualified Doctors in North America at the helm.

Eventually this will take a life of its own and i'd imagine 6 months from now InMed will be in another league.

Keep Last Read

Replies (1) Next 10 Prev Next

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:

Detailed Quote

Recent INM News

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors • Edgar (US Regulatory) • 05/27/2026 08:08:16 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/21/2026 09:08:05 PM
Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 05/21/2026 08:51:08 PM
/C O R R E C T I O N -- InMed Pharmaceuticals/ • PR Newswire (US) • 05/20/2026 02:34:00 PM
/C O R R E C T I O N -- InMed Pharmaceuticals/ • PR Newswire (US) • 05/19/2026 06:21:00 PM
InMed-Mentari Migraine Merger Backed by $290 Million Financing Reshapes Company Strategy (INM) • IH Market News • 05/19/2026 02:37:16 PM
Form 425 - Prospectuses and communications, business combinations • Edgar (US Regulatory) • 05/19/2026 02:34:05 PM
Form 8-K - Current report • Edgar (US Regulatory) • 05/19/2026 02:32:30 PM
InMed Pharmaceuticals & Mentari Therapeutics Announce Merger to Advance Migraine Prevention Therapies • PR Newswire (US) • 05/19/2026 12:00:00 PM
Form 8-K - Current report • Edgar (US Regulatory) • 05/19/2026 10:03:08 AM
InMed Pharmaceuticals Amends Preferred Investment Options • Newsfile • 05/19/2026 10:00:00 AM
InMed Reports Third Quarter Fiscal 2026 Financial Results and Provides Business Update • Newsfile • 05/06/2026 10:00:00 PM
Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/06/2026 09:25:11 PM
InMed Pharmaceuticals Amends Preferred Investment Options • Newsfile • 04/27/2026 09:30:00 PM
Form 8-K - Current report • Edgar (US Regulatory) • 04/27/2026 08:58:16 PM
Form 8-K - Current report • Edgar (US Regulatory) • 04/03/2026 08:19:20 PM
Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 04/03/2026 08:17:05 PM
Form 8-K - Current report • Edgar (US Regulatory) • 03/30/2026 09:37:48 PM
InMed Pharmaceuticals Receives Nasdaq Notification Regarding Minimum Bid Price Compliance • Newsfile • 03/27/2026 09:05:00 PM
Form 8-K - Current report • Edgar (US Regulatory) • 03/23/2026 11:31:26 AM
InMed Pharmaceuticals Announces Positive Data from Human Brain Organoid Neuroinflammation Models Supporting the INM-901 Alzheimer's Disease Program • Newsfile • 03/23/2026 11:30:00 AM
Form S-3 - Registration statement under Securities Act of 1933 • Edgar (US Regulatory) • 03/20/2026 09:00:29 PM
Sidoti Events, LLC's March Small-Cap Virtual Conference • ACCESS Newswire • 03/18/2026 12:00:00 PM
Form 8-K - Current report • Edgar (US Regulatory) • 03/09/2026 11:43:44 AM

Volume
Day Range:
Bid Price
Ask Price
Last Trade Time:

Boards:

Quotes:

Boards

News

Market Data

Markets

Discover

Discover

Boards:

Quotes:

Detailed Quote

Recent INM News

More INM News

Boards:

Quotes:

Boards

News

Market Data

Markets

Discover

Discover

Boards:

Quotes:

Recent INM News

Go Ad-Free